Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Clowns 🤡 getting aggressive here

<< Previous

Bullboard Posts

Next >>

Comment by Bangadaon Feb 08, 2022 12:30pm

90 Views

Post# 34409073

RE:Clowns 🤡 getting aggressive here

Do you know what the horseshoe theorem is? You should be just as shamefull as mindless bashers for luring naive people into this stock which accompanied by a horrible management and shady shell game tactics to enrich the CEO. The only good thing is the drug, but when the management does not want to bring it over the line, it does not matter how good the drug is.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing